Search Results

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

• Authors : PR Newswire

Subjects: Switzerland; Massachusetts

• Source: PR Newswire US. 04/17/2024.

Record details

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

• Authors : PR Newswire

Subjects: Massachusetts; Switzerland; Canada

• Source: PR Newswire US. 03/20/2024.

Record details

PathAI Present Machine Learning Models that Predict the Homologous Recombination Deficiency Status of Breast Cancer Biopsies at the 2020 SABCS

• Authors : PR Newswire

Subjects: Massachusetts

• Source: PR Newswire US. 12/09/2020.

Record details

Senhwa Announces First Patient Successfully Dosed in Phase 1b Expansion Study of Pidnarulex to Treat Solid Tumors with Specific Homologous Recombination Gene Mutations

• Authors : PR Newswire

Subjects: Taiwan; California

• Source: PR Newswire US. 09/10/2021.

Record details

LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevacizumab for Homologous Recombination Deficient (HRD)-Positive Advanced Ovarian Cancer

• Authors : Merck & Co., Inc.

• Source: Business Wire (English). 09/22/2022.

Record details

SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies

• Authors : PR Newswire

Subjects: Massachusetts; Switzerland

• Source: PR Newswire US. 02/24/2022.

Record details

Cellworks Biosimulation Predicts PARPi Benefit in Patients with Ovarian, Pancreatic, Prostate and Triple-Negative Breast Cancers

• Authors : Cellworks Group Inc.

• Source: Business Wire (English). 09/16/2024.

Record details

IDEAYA Biosciences Announces Clearance of IND Application for Pol Theta Helicase Development Candidate GSK101 (IDE705)

• Authors : PR Newswire

Subjects: California

• Source: PR Newswire US. 08/21/2023.

Record details

University of Minnesota Grants Calyxt an Exclusive License to its Homologous Recombination Technology in Plants

• Authors : Calyxt, Inc.

• Source: Business Wire (English). 07/28/2015.

Record details

Cellectis grants genOway an exclusive sublicense for its homologous recombination technology in the field of genetically modified rodent models

• Authors : Cellectis

• Source: Business Wire (English). 02/04/2014.

Record details